SCHEMBL3670007

SCHEMBL3670007

[CH2]C(O)COC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6966711 0.81 TDP1 (0.46)
SCHEMBL1440611 0.79
SCHEMBL198125 0.78 TSHR (0.65)
SCHEMBL14130601 0.78 TDP1 (0.48)
SCHEMBL8079639 0.78 TDP1 (0.48)
SCHEMBL304203 0.78 TDP1 (0.54)
SCHEMBL2152842 0.76
SCHEMBL2152767 0.76
SCHEMBL36039 0.76
SCHEMBL20237150 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214660-A1 Compounds and Methods for the Inhibition of the Expression of VCAM-1 CRABTREE ACQUISITION CO, LLC 2008-09-04 US claimed
US-20080176934-A1 Use Of Diosmetin Compounds In The Treatment And Prevention Of Thrombotic Pathologies LES LABORATOIRES SERVIER (FR) 2008-07-24 US claimed
EP-1726582-A2 Compounds and methods for the inhibition of the expression of vcam-1 Atherogenics, Inc. (US) 2006-11-29 EP claimed
EP-1695959-A1 Compouds and methods for the inhibition of the expression of VCAM-1 Atherogenics, Inc. (US) 2006-08-30 EP claimed
US-20020177717-A1 Compounds and methods for the inhibition of the expression of VCAM-1 CRABTREE ACQUISITION CO, LLC 2002-11-28 US claimed
US-6436919-B1 LOCAL ANESTHETICS THAT HAVE LONGER DURATION OF ACTION WHILE REDUCING UNDESIRED SIDE EFFECTS THERAVANCE INC. 2002-08-20 US claimed
EP-1216243-A1 QUINAZOLINONES AND ANALOGUES AND THEIR USE AS LOCAL ANESTHETICS Advanced Medicine, Inc. (US) 2002-06-26 EP claimed
WO-2001025234-A1 QUINAZOLINONES AND ANALOGUES AND THEIR USE AS LOCAL ANESTHETICS ADVANCED MEDICINE, INC. (US) 2001-04-12 WO claimed
CN-1058494-C New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them ADIR (FR) 2000-11-15 CN claimed
EP-0994853-A2 COMPOUNDS AND METHODS FOR THE INHIBITION OF THE EXPRESSION OF VCAM-1 Atherogenics, Inc. (US) 2000-04-26 EP claimed
EP-0709383-B1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1999-12-15 EP claimed
WO-1998051662-A2 COMPOUNDS AND METHODS FOR THE INHIBITION OF THE EXPRESSION OF VCAM-1 ATHEROGENICS, INC. (US) 1998-11-19 WO claimed
US-5629339-A CHRONIC VENOUS INSUFFICIENCY ADIR ET COMPAGNIE (FR) 1997-05-13 US claimed
CN-1129701-A New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1996-08-28 CN claimed
US-4505923-A GLAUCOMA MERCK & CO., INC. (US) 1985-03-19 US claimed
CN-112955115-B Bioenergy glyceryl nicotinate, compositions and methods of using the same 联合利华知识产权控股有限公司 2023-06-30 CN disclosed
EP-1454921-B1 RADICAL POLYMERIZATION CATALYSTS AND ADHESIVE KIT FOR DENTAL USE TOKUYAMA CORP (JP) 2021-07-28 EP disclosed
EP-0056962-B1 N-SUBSTITUTED POLYGLYCIDYL URAZOL COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Henkel Kommanditgesellschaft auf Aktien (DE) 1985-10-02 EP disclosed
US-4393060-A ANTICANCER HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1983-07-12 US disclosed
EP-0056962-A2 N-substituted polyglycidyl urazol compounds, process for their preparation and pharmaceutical compositions containing them Henkel Kommanditgesellschaft auf Aktien (DE) 1982-08-04 EP disclosed